OPHTHALMOLOGY PACS MARKET ANALYSIS

Ophthalmology Pacs Market Size and Trends

The Ophthalmology PACS market is estimated to be valued at USD 170.1 Mn in 2024 and is expected to reach USD 295.5 Mn by 2031, growing at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031. This market allows for efficient and effective imaging solutions for eye care, helping address the growing prevalence of eye diseases.

Discover market dynamics shaping the industry: Request sample copy

Ophthalmology PACS Market Trend

The ophthalmology PACS market is driven by the rising geriatric population and the subsequent increase in optic disorders. Additionally, government initiatives to modernize eye care infrastructure along with growing investments by industry players to develop advanced imaging solutions will boost the market growth. Integrating new technologies like artificial intelligence promises to further augment the efficient diagnostics and management of ophthalmic disorders.

Increasing prevalence of ophthalmic diseases

The increasing prevalence of various ophthalmic diseases across the globe is one of the primary factors fueling the growth of the ophthalmology PACS market. Eye disorders such as age-related macular degeneration, diabetic retinopathy, glaucoma, cataract, and others have been rising steadily over the past few years. For instance, according to projections by the WHO, the number of people suffering from age-related macular degeneration globally is expected to increase from 195 million in 2020 to 288 million by 2030. Diabetic retinopathy also affects over one-third of the growing diabetic population worldwide.

This upsurge in ocular diseases can partially be attributed to the rapid aging of population coupled with the rising global prevalence of conditions like diabetes that enhance the risk of associated eye disorders. Advanced age and chronic diseases make it more likely for complications to occur in the eyes over the years. Greater life expectancy has significant implications as age-related eye problems pose a huge threat. For instance, in July 2023, according to a Review of Cornea and Contact Lenses, U.S.-based researchers studied chronic age-related eye diseases in Medicare beneficiaries from 2005 to 2020. They found higher diagnosed prevalence of AMD, Age-Related Macular Degeneration diabetic retinopathy, and glaucoma compared to previous estimates. AMD prevalence rose, while any diagnosed DR decreased slightly but vision-threatening DR increased. Glaucoma prevalence decreased slightly.

Market Concentration and Competitive Landscape

Get actionable strategies to beat competition: Request sample copy

Technological Advancements in Diagnostic Imaging Modalities

Ophthalmic diagnostic technologies have witnessed rapid technological upgrades in recent years. Advanced imaging modalities such as optical coherence tomography, fundus camera, and ultrasound biomicroscopy enable high-resolution visualization of internal ocular structures. These technologies generate high volume digital images and scans which need to be systematically archived, compared and evaluated by retinal specialists and ophthalmologists. Traditional film-based data storage is no longer sufficient to handle these digitally captured images effectively. PACS, Picture Archiving and Communication Systems solutions provide a digital platform to efficiently store, retrieve, share and analyze voluminous retina imaging data online. This streamlines clinical workflow and supports timely diagnosis. Continuous technological upgrades in ophthalmic imaging coupled with the need for digital image management will propel the uptake of PACS systems globally in the coming years. For instance, as per a PubMed article from May 2022, survey results revealed high performance of PACS systems in information display and reducing patient identification errors compared to paper-based methods. Ophthalmologists gave positive feedback, especially when integrated with EHR or cloud systems. Government initiatives like World Glaucoma Week, promoting awareness and early diagnosis, also contribute to market growth. Rising awareness of eye diseases like glaucoma increases ophthalmic consultations, boosting the integrated PACS system growth.

Key Takeaways of Analyst:

The ophthalmology PACS market is expected to experience steady growth over the next five years. Growing prevalence of eye diseases and increasing need for efficient medical imaging systems will drive further adoption of ophthalmology PACS. Additionally, rising geriatric population who are more prone to eye disorders will boost demand. North America currently dominates due to high awareness and early technology adoption. However, Asia Pacific is poised to be the fastest growing region supported by increasing healthcare investments and expanding eye care infrastructure in countries like China and India.

The market has good opportunities for revenue growth. Advancements in artificial intelligence and cloud-based technologies may allow ophthalmology PACS providers to expand their offerings. Integration of AI tools could help boost efficiency and early detection of eye issues. Rising tele-ophthalmology practices also provide opportunities to deliver remote diagnosis. Nevertheless, data privacy concerns and cybersecurity threats remain key challenges that need to be addressed. High initial costs of these systems may discourage some smaller clinics and hospitals from investing. Interoperability issues with other hospital IT systems is another potential restraint if not properly addressed by vendors.

Market Challenges: High installation and maintenance costs of PACS

High installation and maintenance costs of PACS deter many small ophthalmology clinics and hospitals from adopting these systems. Lack of IT expertise and digital infrastructure in certain regions also poses implementation challenges. Data security and privacy concerns surround the sharing of patient imaging data on these systems. Interoperability between different vendor products remains an issue, restricting seamless sharing of records. Rising healthcare costs and budget constraints in many countries further limit upgrades to newer PACS technologies.

Market Opportunities: The aging global population susceptible to eye diseases

The aging global population susceptible to eye diseases represents increased demand. Advancing digital healthcare and government incentives for healthcare IT adoption are boosting investments. Cloud-based teleradiology solutions allow remote image sharing and consultations. Integration of artificial intelligence and analytics provides chance for predictive diagnostics and workflow improvements.

Discover high revenue pocket segments and roadmap to it: Request sample copy

By Type: Convenience and Cost-effectiveness Drive the Adoption of Integrated PACS

In terms of type, integrated PACS is expected to contribute the highest share of the market, accounting for 61.3  owing to its convenience and cost-effectiveness over standalone PACS. Integrated PACS offers a unified software platform that allows centralized access, sharing, retrieval, and archiving of patient imaging data and reports. This streamlines workflows and facilitates collaboration between radiologists, ophthalmologists, and other care team members. Managing all imaging modalities and patient records on a single system eliminates data silos and compatibility issues faced with multiple standalone PACS. It also avoids expensive software licensing and maintenance costs associated with numerous point solutions. Integrated PACS provide seamless interoperability within and across healthcare facilities, enabling efficient follow-up care and referrals. Their ease of use and one-stop solution appeals to both large hospitals and specialized clinics looking to digitize their ophthalmology imaging management.

Insights By Delivery Model: Growing Adoption of Cloud-based Platforms Drive the Ophthalmology PACS Market

In terms of delivery model, the cloud-based model is expected to contribute the highest share of the market, accounting for 59.22% due to the growing adoption of cloud platforms. Cloud PACS offer the key advantages of scalability, flexibility, and reduced upfront capital investment over on-premise models. They enable providers to access diagnostic images, review reports, and collaborate with specialists anytime, anywhere via internet-enabled devices. This aligns well with the shift toward tele-ophthalmology and virtual consultations. Cloud platforms also automate software/hardware maintenance and upgrades, freeing up resources for direct patient care. Their pay-as-you-go pricing models have boosted affordability, especially for small to mid-sized clinics. Rapid digitization post-COVID-19 has further accelerated subscription to cloud-based PACS seeking remote work enablement.

Insights By End User: Technological Advancements and Growing Patient Pool Fuel the Hospital Adoption

In terms of end user, hospitals is expected to contribute the highest share of the market, account for 45.32%, driven by several factors. Hospitals manage large volumes of complex patients requiring comprehensive ophthalmic care and diagnosis. To enhance efficiency, many hospitals are automating workflows and transitioning from conventional file rooms to digital PACS. Government initiatives promoting hospital EMR/EHR adoption also propel PACS installations. Moreover, the rising prevalence of eye diseases due to an aging population, diabetes, lifestyle changes, etc. has increased workload on ophthalmology departments. State-of-the-art PACS equipped with AI and connected capabilities help hospitals improve productivity and expand service reach to meet growing demand. Their investments in cutting-edge technologies and larger budget allocations compared to other segments further cements hospital leadership in the ophthalmology PACS market.

Regional Insights

To learn more about this report, Request sample copy

North America continues to dominate the ophthalmology PACS market. The region is expected to account for 40.2 % of the market share in 2024. With a strong healthcare infrastructure and high healthcare expenditure, the U.S. accounts for the majority of the regional market share. Key players in this region have established robust supply chains and distribution networks to cater to the large patient population base effectively. In addition, favorable government policies supporting the digitization of health records are boosting the adoption of PACS solutions across eye care facilities. With the goal of improving diagnostic accuracy and clinical workflow efficiency, leading hospitals and retinal clinics in the U.S. have upgraded their imaging systems with advanced PACS offerings.

Asia Pacific is poised to witness the fastest growth in the ophthalmology PACS market over the forecast period. Rapidly developing economies such as China and India are experiencing increased investment from both public and private sectors to modernize their eye care sector. This has created lucrative opportunities for PACS vendors to penetrate these untapped markets. Moreover, growing medical tourism as well as rising incidence of eye disorders due to aging population are fueling demand. Local manufacturers are also entering strategic collaborations with global PACS giants to strengthen their presence. Favorable government initiatives promoting digital health are further supporting the regional market expansion.

Market Report Scope

Ophthalmology Pacs Industry News

• In May 2022, OMNY Health, a healthcare ecosystem that connects providers and life sciences companies, collaborated with community-based ophthalmology practices to introduce a real-world data ecosystem aimed at fostering collaborative research partnerships to advance treatments and enhance outcomes for patients with ophthalmic disorders.
• In April 2022, ZEISS Medical Technology, diagnostic equipment company, obtained FDA approval for its groundbreaking product, QUATERA 700, which represents a significant advancement in phaco technology. The ZEISS QUATERA 700 is engineered to enhance a surgeon's workflow efficiency from the clinic to the operating room (OR), facilitating a digitally integrated surgical workflow.
• In April 2021, Carl Zeiss Meditec, leading medical technology companies acquired two surgical equipment manufacturers, Kogent Surgical and Katalyst Surgical, in an effort to expand its business and provide enhanced surgical solutions, particularly for ophthalmic medical conditions.
• In November 2020, EyeMD EMR Healthcare Systems Inc., a prominent supplier of Electronic Medical Records (EMR) software tailored for ophthalmologists, is set to introduce EyeMD EMR 2.0, a comprehensive EMR, PM, and PACS system, at the American Academy of Ophthalmology (AAO) Virtual Conference occurring from November 13–15, 2020. AAO stands as the largest association of eye physicians and surgeons globally.

*Definition: The ophthalmology PACS market involves the integration of a picture archiving and communication system (PACS) specifically designed for ophthalmology practices and eye clinics. An ophthalmology PACS allows eye doctors and clinicians to digitally access, store, manage, and view patient eye scans, images, and reports from different ophthalmic imaging modalities like optical coherence tomography, fundus imaging, ultrasound biomicroscopy, etc. centralized in one location.

Market Segmentation

• Type Insights (Revenue, USD Mn, 2019 - 2031)
  • Integrated PACS
  • Standalone PACS
•  Delivery Model Insights (Revenue, USD Mn, 2019 - 2031)
  • Cloud-Based Model
  • On-Premise Model
•  End User Insights (Revenue, USD Mn, 2019 - 2031)
  • Hospitals
  • Speciality Clinics
  • Ambulatory Surgical Centres
  • Others (Academic & Research Institutes) etc.
• Regional Insights (Revenue, USD Mn, 2019 - 2031)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Carl Zeiss Meditec AG
  • Topcon Corporation
  • Heidelberg Engineering GmbH
  • Sonomed Escalon
  • Visbion
  • EyePACS, LLC
  • VersaSuite
  • Merge Healthcare Inc (IBM Watson Health)
  • ScImage, Inc.
  • Agfa-Gevaert N.V.
  • Carl Zeiss Meditec AG
  • IBM Corporation
  • Medical Standard Co, Ltd
  • Topcon Operation
  • Canon Usa Inc.